Title |
The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
|
---|---|
Published in |
Psychopharmacology, October 2010
|
DOI | 10.1007/s00213-010-2036-z |
Pubmed ID | |
Authors |
Felipe V. Gomes, Leonardo B. M. Resstel, Francisco S. Guimarães |
Abstract |
Cannabidiol (CBD) is a non-psychotomimetic compound from Cannabis sativa that induces anxiolytic-like effects in rodents and humans after systemic administration. Previous results from our group showed that CBD injection into the bed nucleus of the stria terminalis (BNST) attenuates conditioned aversive responses. The aim of this study was to further investigate the role of this region on the anxiolytic effects of the CBD. Moreover, considering that CBD can activate 5-HT1A receptors, we also verified a possible involvement of these receptors in those effects. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 25% |
Unknown | 3 | 75% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 166 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 2% |
United Kingdom | 2 | 1% |
Portugal | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 159 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 33 | 20% |
Student > Ph. D. Student | 31 | 19% |
Student > Master | 18 | 11% |
Researcher | 14 | 8% |
Professor | 8 | 5% |
Other | 23 | 14% |
Unknown | 39 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 32 | 19% |
Neuroscience | 25 | 15% |
Medicine and Dentistry | 20 | 12% |
Psychology | 15 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 7% |
Other | 14 | 8% |
Unknown | 49 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2019.
All research outputs
#5,326,693
of 25,257,066 outputs
Outputs from Psychopharmacology
#1,349
of 5,643 outputs
Outputs of similar age
#22,373
of 105,130 outputs
Outputs of similar age from Psychopharmacology
#14
of 40 outputs
Altmetric has tracked 25,257,066 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,643 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,130 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.